A Dose-Ranging Study of IPH2201 in Patients With Gynecologic Malignancies
Clinical trial NCT02459301 · COMPLETED
Trial details
- NCT number
- NCT02459301
- Sponsor
- Canadian Cancer Trials Group
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-17
- Primary completion
- 2017-11-15
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.